1. Introduction
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research Methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of the Industry
2.3. Market Sizing and Forecasting
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.3. Market Share Analysis
2.4. Assumptions for the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Drivers
4.2.1. Increasing Pharmaceutical Research Spending
4.2.2. Rising Prevalence of Target Diseases
4.2.3. Technological Advancements in Biomarker Detection
4.2.4. Rising Focus on Clinical Research
4.2.5. Increasing Funding for Biomarker Research
4.2.6. Rising Focus on Early Disease Diagnosis
4.2.7. Applications of Biomarkers in Multiple Areas
4.3. Restraints
4.3.1. High Capital Investment for Biomarker Discovery
4.3.2. Lengthy Timeline for Biomarker Development
4.4. Opportunities
4.4.1. Rising Funding for R&D
4.4.2 Rising Focus on Companion Diagnostics
4.4.3. Ongoing Research on Biomarkers
4.4.4. Shift Towards Precision Oncology
4.5. Challenges
4.5.1. Challenges Associated with Biomarkers Validation
4.5.2. Technical Issues Related to Sample Collection and Storage
4.6. Factor Analysis
4.7. Trends
4.8. Regulatory Analysis
4.9. Porter’s Five Force Analysis
5. Biomarkers Market Assessment—by Biomarker Type
5.1. Overview
5.2. Efficacy Biomarkers
5.2.1. Prognostic Biomarkers
5.2.2. Pharmacodynamic Biomarkers
5.2.3. Surrogate Biomarkers
5.2.4. Predictive Biomarkers
5.3. Validation Biomarkers
5.4. Safety Biomarkers
6. Biomarkers Market Assessment—by Offerings
6.1. Overview
6.2. Consumables
6.2.1. Assay Kits
6.2.2. Reagents
6.2.3. Other Consumables
6.3. Services & Software
7. Biomarkers Market Assessment—by Mechanism
7.1. Overview
7.2. Genetic Biomarkers
7.3. Epigenetic Biomarkers
7.4. Proteomic Biomarkers
7.5. Lipidomic Biomarkers
7.6. Other Mechanisms
8. Biomarkers Market Assessment—by Profiling Technology
8.1. Overview
8.2. Immunoassay
8.2.1. ELISA
8.2.2. Western Blot
8.2.3. Protein Microarray
8.3. NGS
8.4. PCR
8.5. Mass Spectrometry
8.6. Chromatography
8.7. Other Technologies
9. Biomarkers Market Assessment—by Disease Type
9.1. Overview
9.2. Oncology
9.3. Cardiovascular Diseases
9.4. Infectious Diseases
9.5. Neurological Disorders
9.6. Diabetes and Other Metabolic Diseases
9.7. Other Diseases
10. Biomarkers Market Assessment—by Application
10.1. Overview
10.2. Diagnostics
10.3. Drug Discovery and Development
10.4. Personalized Medicine
10.5. Clinical Research
10.6. Other Applications
11. Biomarkers Market Assessment—by End User
11.1. Overview
11.2. Pharmaceutical & Biotechnology Companies
11.3. Hospitals
11.4. Diagnostic Laboratories
11.5. Other End Users
12. Biomarkers Market Assessment—by Geography
12.1. Overview
12.2. North America
12.2.1. U.S.
12.2.2. Canada
12.3. Europe
12.3.1. Germany
12.3.2. France
12.3.3. U.K.
12.3.4. Italy
12.3.5. Spain
12.3.6. Switzerland
12.3.7. Belgium
12.3.8. Netherlands
12.3.9. Rest of Europe (RoE)
12.4. Asia-Pacific
12.4.1. Japan
12.4.2. China
12.4.3. India
12.4.4. South Korea
12.4.5. Rest of Asia-Pacific (RoAPAC)
12.5. Latin America
12.6. Middle East & Africa
13. Competition Analysis
13.1. Overview
13.2. Key Growth Strategies
13.3. Competitive Benchmarking
13.4. Competitive Dashboard
13.4.1. Industry Leaders
13.4.2. Market Differentiators
13.4.3. Vanguards
13.4.4. Emerging Companies
13.5. Market Share Analysis/Market Ranking, by Key Players (2023)
14. Company Profiles (Company Overview, Financial Overview, Product Portfolio, and Strategic Developments)
14.1. F. Hoffmann-La Roche AG
14.2. Merck KGaA
14.3. Epigenomics AG
14.4. Abbott Laboratories
14.5. QIAGEN N.V.
14.6. Bio-Rad Laboratories
14.7. Revvity Inc.
14.8. Siemens Healthineers AG
14.9. Mindray
14.10. Eurofins Scientific SE
14.11. bioMérieux SA
14.12. Agilent Technologies, Inc.
14.13. Quanterix Corp.
14.14. Thermo Fisher Scientific Inc.
(Note: SWOT analysis of the top 5 companies will be provided.)
15. Appendix
15.1. Available Customization
15.2. Related Reports
List of Tables
Table 1 Global Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 2 Global Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 3 Global Efficacy Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 4 Global Prognostic Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 5 Global Pharmacodynamic Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 6 Global Surrogate Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 7 Global Predictive Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 8 Global Validation Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 9 Global Safety Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 10 Global Biomarkers Market, by Offerings, 2022–2031 (USD Million)
Table 11 Global Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 12 Global Biomarkers Market for Consumables, by Country/Region, 2022–2031 (USD Million)
Table 13 Global Biomarkers Market for Assay Kits, by Country/Region, 2022–2031 (USD Million)
Table 14 Global Biomarkers Market for Reagents, by Country/Region, 2022–2031 (USD Million)
Table 15 Global Biomarkers Market for Other Consumables, by Country/Region, 2022–2031 (USD Million)
Table 16 Global Biomarkers Market for Services & Software, by Country/Region, 2022–2031 (USD Million)
Table 17 Global Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 18 Global Genetic Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 19 Global Epigenetic Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 20 Global Proteomic Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 21 Global Lipidomic Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 22 Global Biomarkers Market for Other Mechanisms, by Country/Region, 2022–2031 (USD Million)
Table 23 Global Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 24 Global Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 25 Global Biomarkers Market for Immunoassay, by Country/Region, 2022–2031 (USD Million)
Table 26 Global Biomarkers Market for ELISA, by Country/Region, 2022–2031 (USD Million)
Table 27 Global Biomarkers Market for Western Blot, by Country/Region, 2022–2031 (USD Million)
Table 28 Global Biomarkers Market for Protein Microarray, by Country/Region, 2022–2031 (USD Million)
Table 29 Global Biomarkers Market for NGS, by Country/Region, 2022–2031 (USD Million)
Table 30 Global Biomarkers Market for PCR, by Country/Region, 2022–2031 (USD Million)
Table 31 Global Biomarkers Market for Mass Spectrometry, by Country/Region, 2022–2031 (USD Million)
Table 32 Global Biomarkers Market for Chromatography, by Country/Region, 2022–2031 (USD Million)
Table 33 Global Biomarkers Market for Other Technologies, by Country/Region, 2022–2031 (USD Million)
Table 34 Global Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 35 Global Biomarkers Market for Oncology, by Country/Region, 2022–2031 (USD Million)
Table 36 Global Biomarkers Market for Cardiovascular Diseases, by Country/Region, 2022–2031 (USD Million)
Table 37 Global Biomarkers Market for Infectious Diseases, by Country/Region, 2022–2031 (USD Million)
Table 38 Global Biomarkers Market for Neurological Disorders, by Country/Region, 2022–2031 (USD Million)
Table 39 Global Biomarkers Market for Diabetes and Other Metabolic Diseases, by Country/Region, 2022–2031 (USD Million)
Table 40 Global Biomarkers Market for Other Diseases, by Country/Region, 2022–2031 (USD Million)
Table 41 Global Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 42 Global Biomarkers Market for Diagnostics, by Country/Region, 2022–2031 (USD Million)
Table 43 Global Biomarkers Market for Drug Discovery and Development, by Country/Region, 2022–2031 (USD Million)
Table 44 Global Biomarkers Market for Personalized Medicine, by Country/Region, 2022–2031 (USD Million)
Table 45 Global Biomarkers Market for Clinical Research, by Country/Region, 2022–2031 (USD Million)
Table 46 Global Biomarkers Market for Other Applications, by Country/Region, 2022–2031 (USD Million)
Table 47 Global Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 48 Global Biomarkers Market for Pharmaceutical & Biotechnology Companies, by Country/Region, 2022–2031 (USD Million)
Table 49 Global Biomarkers Market for Hospitals, by Country/Region, 2022–2031 (USD Million)
Table 50 Global Biomarkers Market for Diagnostic Laboratories, by Country/Region, 2022–2031 (USD Million)
Table 51 Global Biomarkers Market for Other End Users, by Country/Region, 2022–2031 (USD Million)
Table 52 Global Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 53 North America: Biomarkers Market, by Country, 2022–2031 (USD Million)
Table 54 North America: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 55 North America: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 56 North America: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 57 North America: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 58 North America: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 59 North America: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 60 North America: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 61 North America: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 62 North America: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 63 North America: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 64 U.S.: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 65 U.S.: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 66 U.S.: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 67 U.S.: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 68 U.S.: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 69 U.S.: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 70 U.S.: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 71 U.S.: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 72 U.S.: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 73 U.S.: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 74 Canada: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 75 Canada: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 76 Canada: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 77 Canada: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 78 Canada: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 79 Canada: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 80 Canada: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 81 Canada: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 82 Canada: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 83 Canada: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 84 Europe: Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 85 Europe: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 86 Europe: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 87 Europe: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 88 Europe: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 89 Europe: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 90 Europe: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 91 Europe: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 92 Europe: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 93 Europe: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 94 Europe: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 95 Germany: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 96 Germany: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 97 Germany: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 98 Germany: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 99 Germany: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 100 Germany: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 101 Germany: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 102 Germany: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 103 Germany: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 104 Germany: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 105 France: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 106 France: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 107 France: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 108 France: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 109 France: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 110 France: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 111 France: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 112 France: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 113 France: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 114 France: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 115 U.K.: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 116 U.K.: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 117 U.K.: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 118 U.K.: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 119 U.K.: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 120 U.K.: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 121 U.K.: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 122 U.K.: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 123 U.K.: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 124 U.K.: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 125 Italy: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 126 Italy: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 127 Italy: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 128 Italy: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 129 Italy: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 130 Italy: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 131 Italy: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 132 Italy: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 133 Italy: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 134 Italy: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 135 Spain: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 136 Spain: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 137 Spain: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 138 Spain: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 139 Spain: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 140 Spain: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 141 Spain: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 142 Spain: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 143 Spain: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 144 Spain: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 145 Switzerland: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 146 Switzerland: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 147 Switzerland: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 148 Switzerland: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 149 Switzerland: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 150 Switzerland: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 151 Switzerland: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 152 Switzerland: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 153 Switzerland: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 154 Switzerland: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 155 Belgium: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 156 Belgium: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 157 Belgium: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 158 Belgium: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 159 Belgium: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 160 Belgium: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 161 Belgium: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 162 Belgium: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 163 Belgium: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 164 Belgium: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 165 Netherlands: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 166 Netherlands: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 167 Netherlands: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 168 Netherlands: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 169 Netherlands: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 170 Netherlands: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 171 Netherlands: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 172 Netherlands: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 173 Netherlands: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 174 Netherlands: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 175 Rest of Europe: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 176 Rest of Europe: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 177 Rest of Europe: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 178 Rest of Europe: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 179 Rest of Europe: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 180 Rest of Europe: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 181 Rest of Europe: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 182 Rest of Europe: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 183 Rest of Europe: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 184 Rest of Europe: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 185 Asia-Pacific: Biomarkers Market, by Country/Region, 2022–2031 (USD Million)
Table 186 Asia-Pacific: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 187 Asia-Pacific: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 188 Asia-Pacific: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 189 Asia-Pacific: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 190 Asia-Pacific: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 191 Asia-Pacific: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 192 Asia-Pacific: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 193 Asia-Pacific: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 194 Asia-Pacific: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 195 Asia-Pacific: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 196 China: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 197 China: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 198 China: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 199 China: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 200 China: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 201 China: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 202 China: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 203 China: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 204 China: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 205 China: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 206 Japan: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 207 Japan: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 208 Japan: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 209 Japan: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 210 Japan: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 211 Japan: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 212 Japan: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 213 Japan: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 214 Japan: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 215 Japan: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 216 India: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 217 India: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 218 India: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 219 India: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 220 India: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 221 India: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 222 India: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 223 India: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 224 India: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 225 India: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 226 South Korea: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 227 South Korea: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 228 South Korea: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 229 South Korea: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 230 South Korea: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 231 South Korea: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 232 South Korea: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 233 South Korea: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 234 South Korea: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 235 South Korea: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 236 Rest of Asia-Pacific: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 237 Rest of Asia-Pacific: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 238 Rest of Asia-Pacific: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 239 Rest of Asia-Pacific: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 240 Rest of Asia-Pacific: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 241 Rest of Asia-Pacific: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 242 Rest of Asia-Pacific: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 243 Rest of Asia-Pacific: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 244 Rest of Asia-Pacific: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 245 Rest of Asia-Pacific: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 246 Latin America: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 247 Latin America: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 248 Latin America: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 249 Latin America: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 250 Latin America: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 251 Latin America: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 252 Latin America: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 253 Latin America: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 254 Latin America: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 255 Latin America: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 256 Middle East & Africa: Biomarkers Market, by Biomarker Type, 2022–2031 (USD Million)
Table 257 Middle East & Africa: Efficacy Biomarkers Market, by Type, 2022–2031 (USD Million)
Table 258 Middle East & Africa: Biomarkers Market, by Offering, 2022–2031 (USD Million)
Table 259 Middle East & Africa: Biomarkers Market for Consumables, by Type, 2022–2031 (USD Million)
Table 260 Middle East & Africa: Biomarkers Market, by Mechanism, 2022–2031 (USD Million)
Table 261 Middle East & Africa: Biomarkers Market, by Profiling Technology, 2022–2031 (USD Million)
Table 262 Middle East & Africa: Biomarkers Market for Immunoassay, by Type, 2022–2031 (USD Million)
Table 263 Middle East & Africa: Biomarkers Market, by Disease Type, 2022–2031 (USD Million)
Table 264 Middle East & Africa: Biomarkers Market, by Application, 2022–2031 (USD Million)
Table 265 Middle East & Africa: Biomarkers Market, by End User, 2022–2031 (USD Million)
Table 266 Recent Developments, by Company, 2020–2024
List of Figures
Figure 1 Research Process
Figure 2 Key Secondary Sources
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply-side & Demand-side)
Figure 6 Market Size Estimation
Figure 7 Global Biomarkers Market, by Biomarker Type, 2024 VS. 2031 (USD Million)
Figure 8 Global Biomarkers Market, by Offering, 2024 VS. 2031 (USD Million)
Figure 9 Global Biomarkers Market, by Mechanism, 2024 VS. 2031 (USD Million)
Figure 10 Global Biomarkers Market, by Profiling Technology, 2024 VS. 2031 (USD Million)
Figure 11 Global Biomarkers Market, by Disease Type, 2024 VS. 2031 (USD Million)
Figure 12 Global Biomarkers Market, by Application, 2024 VS. 2031 (USD Million)
Figure 13 Global Biomarkers Market, by End User, 2024 VS. 2031 (USD Million)
Figure 14 Global Biomarkers Market, by Geography
Figure 15 Global Biomarkers Market, by Biomarker Type, 2024 VS. 2031 (USD Million)
Figure 16 Global Biomarkers Market, by Offering, 2024 VS. 2031 (USD Million)
Figure 17 Global Biomarkers Market, by Mechanism, 2024 VS. 2031 (USD Million)
Figure 18 Global Biomarkers Market, by Profiling Technology, 2024 VS. 2031 (USD Million)
Figure 19 Global Biomarkers Market, by Disease Type, 2024 VS. 2031 (USD Million)
Figure 20 Global Biomarkers Market, by Application, 2024 VS. 2031 (USD Million)
Figure 21 Global Biomarkers Market, by End User, 2024 VS. 2031 (USD Million)
Figure 22 Global Biomarkers Market, by Geography, 2024 VS. 2031 (USD Million)
Figure 23 North America: Biomarkers Market Snapshot
Figure 24 Europe: Biomarkers Market Snapshot
Figure 25 Asia-Pacific: Biomarkers Market Snapshot
Figure 26 Key Growth Strategies Adopted by Leading Players, 2020–2024
Figure 27 Global Biomarkers Market: Competitive Benchmarking, by Offerings
Figure 28 Global Biomarkers Market: Competitive Benchmarking, by Geography
Figure 29 Global Biomarkers Market: Competitive Dashboard
Figure 30 Global Biomarkers Market: Market Share Analysis/Market Ranking (2023)
Figure 31 F. Hoffmann-La Roche AG: Financial Snapshot (2023)
Figure 32 Merck KGaA: Financial Snapshot (2023)
Figure 33 Epigenomics AG: Financial Snapshot (2023)
Figure 34 Abbott Laboratories: Financial Snapshot (2023)
Figure 35 QIAGEN N.V.: Financial Snapshot (2023)
Figure 36 Bio-Rad Laboratories: Financial Snapshot (2023)
Figure 37 Revvity Inc.: Financial Snapshot (2023)
Figure 38 Siemens Healthineers AG: Financial Snapshot (2023)
Figure 39 Mindray: Financial Snapshot (2023)
Figure 40 Eurofins Scientific SE: Financial Snapshot (2023)
Figure 41 bioMérieux SA: Financial Snapshot (2023)
Figure 42 Agilent Technologies, Inc.: Financial Snapshot (2023)
Figure 43 Quanterix Corp.: Financial Snapshot (2023)
Figure 44 Thermo Fisher Scientific Inc: Financial Snapshot (2023)